NCT02284334

Brief Summary

The investigators are conducting a research study on nutrition in mitochondrial disease. The investigators are interested in the kind of carbohydrates that people eat. Carbohydrates are an important source of energy. Certain kinds of carbohydrates tend to raise blood sugar more in healthy people, and others tend to raise blood sugar less in healthy people. The investigators would like to know if by eating the "right" type of carbohydrate, people with mitochondrial disease can avoid high lactate levels, high blood sugar levels, and, later, low blood sugars. In this study, this question will be answered by finding out how people with mitochondrial disease respond to two different test meals containing different kinds of carbohydrates. Neither participants nor the investigators will know which kind of test meal participants are eating.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
18

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Oct 2014

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2014

Completed
20 days until next milestone

First Submitted

Initial submission to the registry

October 21, 2014

Completed
16 days until next milestone

First Posted

Study publicly available on registry

November 6, 2014

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2016

Completed
Last Updated

November 20, 2020

Status Verified

November 1, 2020

Enrollment Period

2 years

First QC Date

October 21, 2014

Last Update Submit

November 18, 2020

Conditions

Keywords

mitochondrial diseasesnutritionglycemic index

Outcome Measures

Primary Outcomes (1)

  • lactate area under the curve (AUC) for 3 hours after MMTT

    within-subject change in lactate area under the curve (AUC) for 3 hours (low- vs. high- glycemic index)

    visit 1 (baseline, 0 months), visit 2 (around 1 month)

Secondary Outcomes (4)

  • hypoglycemia (< 70 mg/dL) post-MMTT

    visit 1 (baseline, 0 months), visit 2 (around 1 month)

  • glucose area under the curve (AUC) for 3 hours after MMTT

    visit 1 (baseline, 0 months), visit 2 (around 1 month)

  • insulin area under the curve (AUC) for 3 hours after MMTT

    visit 1 (baseline, 0 months), visit 2 (around 1 month)

  • combined index of attention (CPT-III) during MMTT

    visit 1 (baseline, 0 months), visit 2 (around 1 month)

Study Arms (2)

Low GI-High GI

Two study visits are separate by around one month. For this arm, test meal (Visit 1): low-glycemic index; test meal (Visit 2): high-glycemic index

Other: test meal

High GI-Low GI

Two study visits are separate by around one month. For this arm, test meal (Visit 1): high-glycemic index; test meal (Visit 2): low-glycemic index

Other: test meal

Interventions

low- or high-glycemic index test meal, administered during mixed meal tolerance test

High GI-Low GILow GI-High GI

Eligibility Criteria

Age7 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

patients with mitochondrial diseases, from existing observational cohort study and/or CHOP Genetics/Metabolism clinic

You may qualify if:

  • Weight \> 15 kg
  • Girls ≥ 11 years of age and/or who have achieved menarche must have a negative urine pregnancy test.
  • Genetic and/or biochemical diagnosis of mitochondrial disease.
  • Eat meals by mouth during the day.

You may not qualify if:

  • Diabetes requiring insulin.
  • Receive daytime total parenteral nutrition (TPN) and/or continuous enteral feedings.
  • Prescribed dietary contraindication to mixed meal tolerance testing, e.g., ketogenic diet.
  • Any investigational drug use within 30 days prior to enrollment.
  • Pregnant or lactating females.
  • Persons unable to fast for at least 4 hours.
  • Persons who may be allergic to the test meals (shakes).
  • Parents/guardians or subjects who, in the opinion of the Investigator, may be non-adherent to study schedules or procedures.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Children's Hospital of Philadelphia

Philadelphia, Pennsylvania, 19104, United States

Location

Biospecimen

Retention: SAMPLES WITHOUT DNA

Blood samples obtained during MMTT.

MeSH Terms

Conditions

Mitochondrial Diseases

Condition Hierarchy (Ancestors)

Metabolic DiseasesNutritional and Metabolic Diseases

Study Design

Study Type
observational
Observational Model
CASE CROSSOVER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 21, 2014

First Posted

November 6, 2014

Study Start

October 1, 2014

Primary Completion

October 1, 2016

Study Completion

October 1, 2016

Last Updated

November 20, 2020

Record last verified: 2020-11

Locations